Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001224
Filing Date
2025-01-10
Accepted
2025-01-10 15:01:12
Documents
1
Period of Report
2025-01-07

Document Format Files

Seq Description Document Type Size
1 form4-01102025_080109.html 4  
1 form4-01102025_080109.xml 4 6453
  Complete submission text file 0001415889-25-001224.txt   7878
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address
LaSpaluto Michelle (Reporting) CIK: 0002001106 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35867 | Film No.: 25522501